AIMS: We evaluated whether black race is independently associated with arterial endothelial dysfunction. The pathophysiological basis for race-related differences in cardiovascular disease (CVD) risk has not been established. Endothelial dysfunction, which precedes obstructive atherosclerotic disease, may contribute to CVD disparities. Accordingly, we evaluated race-related differences in digital pulse amplitude tonometry (PAT) response to an endothelium-dependent vasodilatory stimulus. METHODS AND RESULTS: A total of 1377 subjects (41% black; mean age 58.5 ± 7.5 years; 67% female) enrolled in the Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) study underwent assessment of digital pulse amplitude response to forearm occlusion-induced hyperaemia. The response was measured as a PAT ratio of hyperaemia:baseline pulse amplitude in a finger that was subject to hyperaemic stimulus divided by this same ratio in a control finger on the contralateral arm which did not undergo forearm occlusion, expressed as the natural logarithm. The average PAT ratio was significantly lower in blacks compared with whites (0.67 ± 0.44 vs. 0.80 ± 0.46, P < 0.001), signifying greater endothelial dysfunction in blacks. Black race was independently correlated with lower PAT ratio. This finding was consistent across all Framingham risk strata. Adjusted analyses showed significant gender-race interactions. With white women serving as the referent group, parameter estimates for lower PAT ratio in ascending order were as follows: black males (t = -6.93, P < 0.0001); white males (t = -3.31, P = 0.001); and black females (t = -1.12, P = 0.26). CONCLUSION: Our findings indicate that black race is independently associated with arterial endothelial dysfunction. Racial differences in CVD risk may be related, in part, to race-related differences in endothelial dysfunction.
AIMS: We evaluated whether black race is independently associated with arterial endothelial dysfunction. The pathophysiological basis for race-related differences in cardiovascular disease (CVD) risk has not been established. Endothelial dysfunction, which precedes obstructive atherosclerotic disease, may contribute to CVD disparities. Accordingly, we evaluated race-related differences in digital pulse amplitude tonometry (PAT) response to an endothelium-dependent vasodilatory stimulus. METHODS AND RESULTS: A total of 1377 subjects (41% black; mean age 58.5 ± 7.5 years; 67% female) enrolled in the Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) study underwent assessment of digital pulse amplitude response to forearm occlusion-induced hyperaemia. The response was measured as a PAT ratio of hyperaemia:baseline pulse amplitude in a finger that was subject to hyperaemic stimulus divided by this same ratio in a control finger on the contralateral arm which did not undergo forearm occlusion, expressed as the natural logarithm. The average PAT ratio was significantly lower in blacks compared with whites (0.67 ± 0.44 vs. 0.80 ± 0.46, P < 0.001), signifying greater endothelial dysfunction in blacks. Black race was independently correlated with lower PAT ratio. This finding was consistent across all Framingham risk strata. Adjusted analyses showed significant gender-race interactions. With white women serving as the referent group, parameter estimates for lower PAT ratio in ascending order were as follows: black males (t = -6.93, P < 0.0001); white males (t = -3.31, P = 0.001); and black females (t = -1.12, P = 0.26). CONCLUSION: Our findings indicate that black race is independently associated with arterial endothelial dysfunction. Racial differences in CVD risk may be related, in part, to race-related differences in endothelial dysfunction.
Authors: A E Schutte; S Botha; C M T Fourie; L F Gafane-Matemane; R Kruger; L Lammertyn; L Malan; C M C Mels; R Schutte; W Smith; J M van Rooyen; L J Ware; H W Huisman Journal: J Hum Hypertens Date: 2017-03-23 Impact factor: 3.012
Authors: Orlando M Gutiérrez; Suzanne E Judd; Paul Muntner; Dana V Rizk; William M McClellan; Monika M Safford; Mary Cushman; Brett M Kissela; Virginia J Howard; David G Warnock Journal: Neurology Date: 2012-09-19 Impact factor: 9.910
Authors: Ranganath Muniyappa; Vandana Sachdev; Stanislav Sidenko; Madia Ricks; Darleen C Castillo; Amber B Courville; Anne E Sumner Journal: Am J Physiol Endocrinol Metab Date: 2011-11-01 Impact factor: 4.310
Authors: R T Domsic; C Dezfulian; Al Shoushtari; D Ivanco; E Kenny; C K Kwoh; T A Medsger; H C Champion Journal: Clin Exp Rheumatol Date: 2014-11-05 Impact factor: 4.473
Authors: Luisa C C Brant; Naomi M Hamburg; Sandhi M Barreto; Emelia J Benjamin; Antonio L P Ribeiro Journal: J Am Heart Assoc Date: 2014-12-15 Impact factor: 5.501
Authors: Sebhat Erqou; Jane E Clougherty; Oladipupo Olafiranye; Jared W Magnani; Aryan Aiyer; Sheila Tripathy; Ellen Kinnee; Kevin E Kip; Steven E Reis Journal: Arterioscler Thromb Vasc Biol Date: 2018-03-15 Impact factor: 8.311
Authors: Alanna A Morris; Riyaz S Patel; Jose Nilo G Binongo; Joseph Poole; Ibhar Al Mheid; Yusuf Ahmed; Neli Stoyanova; Viola Vaccarino; Rebecca Din-Dzietham; Gary H Gibbons; Arshed Quyyumi Journal: J Am Heart Assoc Date: 2013-04-08 Impact factor: 5.501